Extracted from this filing and checked against the source text.
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Streamex Corp. entered into Securities Purchase Agreement with certain institutional and accredited investors valued at aggregate consideration of $159,997.87 (effective 2023-01-25).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- certain institutional and accredited investors
- Value
- aggregate consideration of $159,997.87
- Effective
- 2023-01-25
Exact text from the filing
On January 25, 2023, BioSig Technologies, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain institutional and accredited investors (the “Investors”), pursuant to which the Company sold to the Investors an aggregate of 196,872 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”) at a purchase price of $0.8127 per share, and warrants (the “Warrants”) to purchase up to 98,436 shares of Common Stock (the “Warrant Shares” and together with the Shares and Warrants, the “Securities”), at an exercise price of $0.7502 per share, that will become exercisable six months after the date of issuance and will expire five and one-half years following the date of issuance, in exchange for aggregate consideration of $159,997.87.
View on SEC.gov